Intelligent Bio Solutions (INBS) Long-Term Deferred Tax (2021 - 2023)
Intelligent Bio Solutions (INBS) recorded quarterly Long-Term Deferred Tax of $7.6 million in Q1 2023, down 6.79% quarter-over-quarter from $8.1 million in Q4 2022, and up 1.17% on a YoY basis from $7.5 million in Q1 2022.
Intelligent Bio Solutions (INBS) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends
Intelligent Bio Solutions' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $7.6 million for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 7.60 Mn |
| Dec 31, 2022 | 8.15 Mn |
| Sep 30, 2022 | 6.33 Mn |
| Mar 31, 2022 | 7.51 Mn |
| Dec 31, 2021 | 6.46 Mn |
| Sep 30, 2021 | 7.22 Mn |